ImmuSmol's News

L-Kynurenine monoclonal antibody to stratify cancer patients - PLOS ONE article

04/20/2015 L-Kynurenine antibody - Cancer patient - IDO1 - Plos One


A recent PLOS ONE article shows that ImmuSmol's anti-L-Kynurenine-antibody can serve to stratify cancer patients for kynurenine pathway activity. Access the article...

More ...

The immune-brain axis: from molecules to behavior

03/02/2015 Immune Brain Axis Symposium


ImmuSmol is sponsoring the Symposium "The immune-brain axis: from molecules to behavior", held at the Hasselt University, Campus Diepenbeek, Belgium, on March 12th and 13th, 2015.

More ...

ImmuSmol's Small Molecule Antibodies in the Press

01/12/2015 ImmuSmol's small molecule antibodies in the press


Discover ImmuSmol's story, featured in the 2015 winter edition of the European Biotechnology Magazine.

More ...

Happy 2015 from ImmuSmol!

01/01/2015


Just a few words to thank our clients and partners and wish them a bright and joyful 2015.

More ...

ImmuSmol raises 500 000 € to advance cancer immunotherapy programme

09/23/2014


ImmuSmol is pleased to announce it has raised 500 000 € to progress its monoclonal antibodies for cancer immunotherapy to in vivo proof-of-concept (POC).

More ...